Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Short term Debt (2016 - 2022)

Fennec Pharmaceuticals (FENC) has disclosed Short term Debt for 8 consecutive years, with $1.0 million as the latest value for Q2 2022.

  • For the quarter ending Q2 2022, Short term Debt changed N/A year-over-year to $1.0 million, compared with a TTM value of $1.0 million through Jun 2022, changed N/A, and an annual FY2017 reading of $167.0 million, up 505960.61% over the prior year.
  • Short term Debt was $1.0 million for Q2 2022 at Fennec Pharmaceuticals, up from $500000.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $1.0 million in Q2 2022 and bottomed at $500000.0 in Q1 2022.